Neisseria meningitidis:: an overview of the carriage state

被引:263
作者
Yazdankhah, SP
Caugant, DA
机构
[1] Norwegian Inst Publ Hlth, Dept Airborne Infect, Div Infect Dis Control, NO-0403 Oslo, Norway
[2] Univ Oslo, Dept Oral Biol, Oslo, Norway
关键词
D O I
10.1099/jmm.0.45529-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
During periods of endemic disease, about 10% of the general population harbour Neisseria meningitidis in the nasopharynx. Since N. meningitidis is a strict human pathogen and most patients have not been in contact with other cases, asymptomatic carriers are presumably the major source of the pathogenic strains. Most carrier isolates are shown to lack capsule production. The capsule deficient state of meningococcal strains in the nasopharynx may aid evasion of the human immune defence and hence be selected to survive nasopharyngeal colonization. Carriage itself can be an immunizing process resulting in systemic protective antibody responses. Frequent nasopharyngeal colonization with related bacteria like Neisseria lactamica improves natural immunity to meningococci by the formation of cross-reacting antibodies. While most meningococcal strains recovered from patients belong to a limited number of clonal groups worldwide, strains isolated from carriers comprise numerous genotypes, with only a small proportion of the strains representing invasive clones. During the carriage state, co-colonization with other pathogenic and nonpathogenic bacteria may lead to genetic exchange, which may result in the emergence of new meningococcal clones. The high diversity of meningococcal carrier strains, compared with hypervirulent strains, supports the idea that transmissibility, not invasion, is essential in the life cycle of N. meningitidis.
引用
收藏
页码:821 / 832
页数:12
相关论文
共 139 条
[1]   PERSISTENCE OF NEISSERIA-MENINGITIDIS IN THE UPPER RESPIRATORY-TRACT AFTER INTRAVENOUS ANTIBIOTIC-THERAPY FOR SYSTEMIC MENINGOCOCCAL DISEASE [J].
ABRAMSON, JS ;
SPIKA, JS .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (02) :370-371
[2]  
Ala'Aldeen DAA, 2000, J CLIN MICROBIOL, V38, P2311
[3]   Molecular characterization of complement components (C3, C4, and factor B) in human saliva [J].
Andoh, A ;
Fujiyama, Y ;
Kimura, T ;
Uchihara, H ;
Sakumoto, H ;
Okabe, H ;
Bamba, T .
JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (05) :404-407
[4]   What about antibiotic resistance in Neisseria lactamica? [J].
Arreaza, L ;
Salcedo, C ;
Alcalá, B ;
Vázquez, JA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) :545-547
[5]   Complete sequence of a β-lactamase-encoding plasmid in Neisseria meningitidis [J].
Bäckman, A ;
Orvelid, P ;
Vazquez, JA ;
Sköld, O ;
Olcén, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) :210-212
[6]   Formation of oligomeric rings by XcpQ and PilQ, which are involved in protein transport across the outer membrane of Pseudomonas aeruginosa [J].
Bitter, W ;
Koster, M ;
Latijnhouwers, M ;
de Cock, H ;
Tommassen, J .
MOLECULAR MICROBIOLOGY, 1998, 27 (01) :209-219
[7]   SECRETOR STATUS, SMOKING AND CARRIAGE OF NEISSERIA-MENINGITIDIS [J].
BLACKWELL, CC ;
WEIR, DM ;
JAMES, VS ;
TODD, WTA ;
BANATVALA, N ;
CHAUDHURI, AKR ;
GRAY, HG ;
THOMSON, EJ ;
FALLON, RJ .
EPIDEMIOLOGY AND INFECTION, 1990, 104 (02) :203-209
[8]   FACTORS AFFECTING CARRIAGE OF NEISSERIA-MENINGITIDIS AMONG GREEK MILITARY RECRUITS [J].
BLACKWELL, CC ;
TZANAKAKI, G ;
KREMASTINOU, J ;
WEIR, DM ;
VAKALIS, N ;
ELTON, RA ;
MENTIS, A ;
FATOUROS, N .
EPIDEMIOLOGY AND INFECTION, 1992, 108 (03) :441-448
[9]   Neisseria meningitidis lipopolysaccharides in human pathology [J].
Brandtzaeg, P ;
Bjerre, A ;
Ovstebo, R ;
Brusletto, B ;
Joo, GB ;
Kierulf, P .
JOURNAL OF ENDOTOXIN RESEARCH, 2001, 7 (06) :401-420
[10]   THE CARRIER STATE - NEISSERIA-MENINGITIDIS [J].
BROOME, CV .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :25-34